Stay updated on Dapagliflozin Sodium Excretion Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin Sodium Excretion Clinical Trial page.

Latest updates to the Dapagliflozin Sodium Excretion Clinical Trial page
- CheckyesterdayChange DetectedThe page shows a new site revision label (v3.4.1) and removal of the previous v3.4.0; no study details, enrollment, or trial information appear to be affected—To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedMinor UI and metadata updates include glossary show/hide controls, capitalization tweaks on labels, and an updated revision indicator (v3.4.0), with no changes to core study content, outcomes, or eligibility details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check23 days agoChange DetectedThe page's revision label was updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check52 days agoChange DetectedFooter now displays Revision: v3.3.3; the HHS Vulnerability Disclosure link and Revision: v3.3.2 were removed.SummaryDifference0.1%

- Check73 days agoChange DetectedPubMed-related publications note updated to indicate automatic population from PubMed and that entries may not relate to the study. The revision stamp on the page was updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check81 days agoChange DetectedA government funding status notice on the ClinicalTrials.gov page was removed. This is a minor administrative update that does not affect study details or eligibility.SummaryDifference0.4%

Stay in the know with updates to Dapagliflozin Sodium Excretion Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin Sodium Excretion Clinical Trial page.